If the test is positive, it allows for earlier treatment, which can significantly improve the chances of a successful outcome. Testing for high-risk HPV genotypes can help determine if a person is at increased risk of developing cervical cancer. The human papillomavirus (HPV) is a common sexually transmitted infection that can cause cervical cancer. Early diagnosis leads to saving lives and stressing the need for prior detection, traditional cervical cancer screening methodologies like the Pap Smear test, visual inspection assay, and liquid-based cytology were being used to identify precancerous changes in a woman’s body.Ĭervical cancer can be prevented or detected at an early stage through molecular diagnostic testing. Today, the country has the most advanced genetic and molecular tests for cancer management. Genetic abnormalities resulting in cancer can be prevented if the right medical test is performed on an individual at the right time. The penultimate law of molecular tests in any disease diagnosis is the appropriate assessment at an early stage. Starting from breast, colorectal, lung, prostate, lymphoma, leukemia, to cervical Cancer, the molecular diagnostics market has been segmented by different products and services. The recent advancements in the field of molecular diagnostics have been towards cancer detection, and this article delves deeper into various applications of how molecular tests have evolved in the field of clinical oncology.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |